查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620517

神經肌肉電刺激器市場機會、成長促進因素、產業趨勢分析和 2024 年至 2032 年預測

Neuromuscular Electric Stimulator Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 134 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球神經肌肉電刺激器市值為3.817 億美元，預計2024 年至2032 年複合年成長率為9.1%。刺激器的需求不斷成長推動的。在攜帶式神經肌肉刺激器創新的推動下，向個人化和家庭治療的轉變進一步推動了市場向前發展。現代設備現在提供無線技術和可自訂的程序，使其更容易滿足個人治療需求。領先衛生機構的監管批准也促進了市場的成長，增強了消費者的信任和採用。

就產品類型而言，市場分為手持式和穿戴式神經肌肉刺激器。 2023 年，手持刺激器的收入最高，達 3.098 億美元。這些設備因其方便和易於使用而受到青睞，特別是對於尋求非侵入性家庭治療關節炎和運動相關損傷等疾病的患者而言。手持式刺激器的緊湊設計使其比大型固定設備更受歡迎。

在檢視最終用途領域時，市場分為醫院、復健中心、家庭護理機構、運動診所和門診手術中心。醫院在 2023 年引領市場，預計到 2032 年將產生 3.21 億美元的收入。中風、多發性硬化症和脊髓損傷等慢性疾病的發病率不斷上升，增加了對先進復健工具的需求，進一步推動了它們在醫院環境中的採用。北美神經肌肉電刺激器市場2023 年收入為1.573 億美元，預計2024 年至2032 年複合年成長率為8.4%。 這種成長是由於人們對運動醫學和健身復健（尤其是運動員）的日益關注所推動的隨著人們對運動相關傷害及其治療的認知不斷增強，神經肌肉刺激器在該地區的診所和訓練設施中得到越來越廣泛的採用。 。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 3.817 億美元
預測值 8.392 億美元
複合年成長率 9.1%

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • NMES 技術的技術進步
      • 對非侵入性治療方案的需求不斷成長
      • 更加重視預防保健
    • 產業陷阱與挑戰
      • 不良反應的風險
  • 成長潛力分析
  • 監管環境
  • 報銷場景
  • 技術景觀
  • 程序見解，（2021 -2032）
    • 膝關節置換手術
    • 髖關節置換手術
    • 踝關節置換手術
  • 臨床應用場景
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 差距分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032

  • 主要趨勢
  • 手持式神經肌肉刺激器
  • 穿戴式神經肌肉刺激器

第 6 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 疼痛管理
  • 肌肉復健
  • 術後恢復
    • 膝關節置換術後康復
    • 髖關節置換術後恢復
    • 踝關節置換恢復
  • 運動醫學

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 復健中心
  • 家庭護理設置
  • 運動診所
  • 門診手術中心

第 8 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • AxioBionics LLC
  • Enovis Corporation
  • Ibramed Medical
  • MTR + Vertriebs GmbH
  • NeuroMetrix, Inc.
  • OMRON Corporation
  • Ottobock
  • RS Medical
  • Sky Medical Technology Ltd.
  • Verity Medical Ltd.
  • Zynex, Inc.
簡介目錄
Product Code: 11802

The Global Neuromuscular Electric Stimulator Market was valued at USD 381.7 million in 2023 and is projected to grow at 9.1% CAGR from 2024 to 2032. This growth is primarily driven by technological advancements, the increasing prevalence of musculoskeletal disorders, and a rising demand for effective rehabilitation solutions. The shift towards personalized and home-based treatments, fueled by innovations in portable neuromuscular stimulators, further propels the market forward. Modern devices now offer wireless technology and customizable programs, making them more accessible for individual therapy needs. Regulatory approvals from leading health agencies have also contributed to the market's growth, enhancing consumer trust and adoption.

In terms of product types, the market is segmented into handheld and wearable neuromuscular stimulators. In 2023, handheld stimulators generated the highest revenue, reaching USD 309.8 million. These devices are favored for their convenience and ease of use, especially for patients seeking non-invasive, at-home treatments for conditions like arthritis and sports-related injuries. The compact design of handheld stimulators makes them preferable over larger, stationary devices.

When examining end-use sectors, the market is divided into hospitals, rehabilitation centers, home care settings, sports clinics, and ambulatory surgical centers. Hospitals led the market in 2023 and are expected to generate USD 321 million by 2032. As primary providers of treatment for musculoskeletal conditions and post-surgical recovery, hospitals are major users of neuromuscular electric stimulators. The rising incidence of chronic illnesses, such as stroke, multiple sclerosis, and spinal cord injuries, has increased the demand for advanced rehabilitation tools, further driving their adoption in hospital settings. The North American neuromuscular electric stimulator market accounted for USD 157.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 8.4% from 2024 to 2032. This growth is fueled by an increasing focus on sports medicine and fitness rehabilitation, particularly among athletes and fitness enthusiasts.As awareness of sports-related injuries and their treatments grows, neuromuscular stimulators are becoming more widely adopted in clinics and training facilities across the region. .

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$381.7 Million
Forecast Value$839.2 Million
CAGR9.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in NMES technologies
      • 3.2.1.2 Growing demand for non-invasive treatment options
      • 3.2.1.3 Increasing focus on preventive care
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk of adverse effects
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
  • 3.7 Procedure insights, (2021 -2032)
    • 3.7.1 Knee replacement procedures
    • 3.7.2 Hip replacement procedures
    • 3.7.3 Ankle replacement procedures
  • 3.8 Clinical applications scenario
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Future market trends
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major key players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld neuromuscular stimulators
  • 5.3 Wearable neuromuscular stimulators

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pain management
  • 6.3 Muscle rehabilitation
  • 6.4 Post-surgical recovery
    • 6.4.1 Knee replacement recovery
    • 6.4.2 Hip replacement recovery
    • 6.4.3 Ankle replacement recovery
  • 6.5 Sports medicine

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Rehabilitation centers
  • 7.4 Home care settings
  • 7.5 Sports clinics
  • 7.6 Ambulatory surgical centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AxioBionics LLC
  • 9.2 Enovis Corporation
  • 9.3 Ibramed Medical
  • 9.4 MTR + Vertriebs GmbH
  • 9.5 NeuroMetrix, Inc.
  • 9.6 OMRON Corporation
  • 9.7 Ottobock
  • 9.8 RS Medical
  • 9.9 Sky Medical Technology Ltd.
  • 9.10 Verity Medical Ltd.
  • 9.11 Zynex, Inc.